Technology News and Research

RSS

WRAIR to test Kane Biotech's DispersinB biofilm technology against pathogens in combat trauma wounds

Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development of products that prevent and remove microbial biofilms is pleased to announce that the Company has entered into a Cooperative Research and Development Agreement for Material Transfer (CRADA-MT) with the Walter Reed Army Institute of Research (WRAIR) in Silver Springs, Maryland.

9 Sep 2009

Silverlink’s Medicare communications solutions to help health plans tackle forthcoming changes in healthcare

Silverlink Communications® Inc., the leader in healthcare consumer communications, today announced solutions focused specifically on the Medicare market. These services help health plans more effectively communicate with beneficiaries, especially important in the 2010 plan year open enrollment season starting in October 2009.

9 Sep 2009

Medpro completes preliminary testing and regulatory requirements for its VACUETTE safety needle system

MedPro Safety Products, Inc. (OTCBB: MPSP), a pioneer in the development and marketing of passive needlestick injury prevention technology, announced today it has completed preliminary testing and regulatory requirements for the VACUETTE® PREMIUM Safety Needle System Tube-Touch model, a single-patient, multiple sample blood collection safety needle system.

9 Sep 2009

Ceragenix awarded $2.87M NIH grant to develop a drug for treating Clostrdium difficile and Shigella

Ceragenix Pharmaceuticals, Inc. (“Ceragenix”) (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that the National Institutes of Health (“NIH”) has awarded a $2.87 million grant to fund the pre clinical development of a Ceragenin™based oral drug to treat two common and potentially deadly gastrointestinal infections: Clostrdium difficile and Shigella.

9 Sep 2009

GENova Biotherapeutics discusses its anti-cancer drug development strategy

GENova Biotherapeutics, Inc., ("GENova"), today released important information about its anti-cancer drug development strategy and its unique niche in the drug development industry.

9 Sep 2009

Neuralstem's patent on neural stem cell transplantation approved

Neuralstem, Inc. today announced that it has received notice of allowance from the United States Patent and Trademark Office (USPTO) for its patent entitled “Transplantation of Human Neural Cells For Treatment Of Neurodegenerative Conditions,” number 11/281,640.

9 Sep 2009

U.S. Navy and Solazyme to develop algae-derived advanced biofuel

Solazyme, Inc., the renewable oil production company and leader in algal synthetic biology, has been selected by the U.S. Department of Defense (DoD) to research, develop, and demonstrate commercial scale production of algae-derived advanced biofuel that meets the United States Navy’s rigorous specifications for military tactical platforms.

9 Sep 2009

Sequoia Hospital completes 1000 atrial fibrillation ablation procedures

Sequoia Hospital announced that the Cardiac Arrhythmia Program has completed 1,000 atrial fibrillation (A-Fib) ablation procedures, making it the highest total volume A-Fib ablation institution currently performing ablations in Northern and Central California.

9 Sep 2009

International Institute of Biomedical Sciences and Technology established for a global research initiative

Upstate Medical University in Syracuse, New York, the Technion-Israel Institute of Technology in Haifa, Israel, and National Cheng Kung University in Tainan City, Taiwan, have announced the creation of the International Institute of Biomedical Sciences and Technology that will facilitate the collaboration of research across three continents and accelerate the development of novel bioengineering, diagnostic and biomedical products for the treatment and cure of disease, officials said today.

9 Sep 2009

TURis plasma vaporization electrode for benign prostatic hyperplasia therapy

The TURis plasma vaporization electrode does not cut off tissue with a loop, but energetically vaporizes the tissue with a small button electrode. With the help of the latest plasma technology, cells can be removed by merely gliding the electrode over the prostate tissue.

From Evident Corporation - Life Sciences 9 Sep 2009

Bayer submits an IND for its MN-IC antibody-drug conjugate to the FDA

Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Bayer Schering Pharma AG, Germany. The milestone was triggered by Bayer’s submission of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for MN-IC, an ADC for solid tumors.

9 Sep 2009

New web-based tool guide practices to become patient-centered medical home

The American College of Physicians (ACP) is offering a new, web-based tool to help guide practices through the process of becoming a patient-centered medical home (PCMH).

9 Sep 2009

iDashboards urges healthcare organizations to update their Information Technology systems

The debate surrounding the current state of US healthcare and its impending reform should not detract healthcare organizations from their ultimate goal of providing superior care to their patients.

9 Sep 2009

Bioluminescence imaging demystifies causes of infectious diseases

By attaching light-emitting genes to infectious bacteria in an experimental system, researchers at University College, Cork, Ireland, have been able to track where in the body the bacteria go - giving an insight into the path of the infection process leading to the development of more targeted treatments.

9 Sep 2009

Prostate cancer treatment options discussed in a study

A new study in the Journal of the American Medical Association (JAMA) appears to support the theory outlined in earlier studies that men with more advanced forms of prostate cancer don't benefit from a combination of hormone and radiation therapy.

9 Sep 2009

Dr. Terry Collins offers public lecture on the growing field of green chemistry

Consumer concerns over hazardous chemicals in the air and water have led scientists to find solutions in the new field of green chemistry. "The most troubling health effects are associated with endocrine disrupting chemicals (EDCs) that may interfere with cellular development in humans and animals," says Dr. Terry Collins, a champion in the field.

9 Sep 2009

Thermo Fisher Scientific receives Ringier Technology Innovation Award

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has received a Ringier Technology Innovation Award for its role in helping Chinese laboratories quickly develop melamine detection capabilities following the discovery of melamine-tainted milk and infant formula in China. The award was presented by Ringier Trade Publishing, which publishes China's leading food industry magazine, Food Manufacturing Journal.

From Thermo Fisher Scientific Inc. 9 Sep 2009

Merck KGaA acquires Suzhou Taizhu Technology Development for € 28 million

Merck KGaA announced today that it has acquired Suzhou Taizhu Technology Development Co. Ltd. ("Taizhu"), a leading supplier of effect pigments located in Taicang near Shanghai, China. With total revenues of more than € 14 million in 2008 and 300 employees Taizhu is one of the biggest effect pigments companies in the Chinese market. The acquisition is of high strategic importance to the Merck pigments business.

9 Sep 2009

Lockton forms health reform advisory practice to help clients deal with changes in health system

Lockton Companies, the world's largest private insurance broker, is offering insights on the impact of health reform through its newly formed Lockton Health Reform Advisory Practice. Lockton's new team provides employers with information, advice, and practical approaches as they respond to health reform legislation and understand impact on their employees and businesses.

9 Sep 2009

Light can be manipulated for creative and lucrative ends

The speed of light, 300 million metres per second, was long thought an immutable constant and has defined our understanding of matter and energy but recent research in the area of optics and photonics is proving that we can manipulate light to some ingenious and hugely lucrative ends.

9 Sep 2009

Technology News and Research

WRAIR to test Kane Biotech's DispersinB biofilm technology against pathogens in combat trauma wounds

Silverlink’s Medicare communications solutions to help health plans tackle forthcoming changes in healthcare

Medpro completes preliminary testing and regulatory requirements for its VACUETTE safety needle system

Ceragenix awarded $2.87M NIH grant to develop a drug for treating Clostrdium difficile and Shigella

GENova Biotherapeutics discusses its anti-cancer drug development strategy

Neuralstem's patent on neural stem cell transplantation approved

U.S. Navy and Solazyme to develop algae-derived advanced biofuel

Sequoia Hospital completes 1000 atrial fibrillation ablation procedures

International Institute of Biomedical Sciences and Technology established for a global research initiative

TURis plasma vaporization electrode for benign prostatic hyperplasia therapy

Bayer submits an IND for its MN-IC antibody-drug conjugate to the FDA

New web-based tool guide practices to become patient-centered medical home

iDashboards urges healthcare organizations to update their Information Technology systems

Bioluminescence imaging demystifies causes of infectious diseases

Prostate cancer treatment options discussed in a study

Dr. Terry Collins offers public lecture on the growing field of green chemistry

Thermo Fisher Scientific receives Ringier Technology Innovation Award

Merck KGaA acquires Suzhou Taizhu Technology Development for € 28 million

Lockton forms health reform advisory practice to help clients deal with changes in health system

Light can be manipulated for creative and lucrative ends

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News